Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

Short answer: there’s no reliable, up‑to‑date public list I can point you to — after the FDA’s warnings many mainstream telehealth platforms stopped offering or promoting compounded GLP‑1 products, and availability now varies by state, prescriber, and individual compounding pharmacy. Because of safety and legal variability, I can’t safely recommend specific providers that “still” compound without checking current, local information.

What I can do now (recommended, safer approach)

• Consider getting an FDA‑approved GLP‑1 (semaglutide, tirzepatide, etc.) through a reputable telehealth clinic that will medically assess and monitor you. These services will manage dosing, labs, side effects, and have clearer supply chains than off‑label compounded products.
  • Examples of telehealth services that commonly prescribe and manage GLP‑1 therapy (FDA‑approved drugs): Hims & Hers, Ro (Rory), PlushCare, One Medical, and SteadyMD. I list these because they provide clinician follow‑up, common coverage/insurance pathways, and transparent prescribing of approved medications — not because they necessarily compound.
• If you believe you need a compounded GLP‑1 for a documented medical reason (severe allergy to an excipient, need for preservative‑free formulation, etc.), ask any qualified telehealth prescriber to document the medical necessity and route the prescription to a state‑licensed, accredited compounding pharmacy. That’s the legal and safer path.

How to find a compounding option safely

1. Ask the telehealth clinician directly: “Do you prescribe compounded GLP‑1s when medically necessary, and which compounding pharmacies do you use?” They should give a named, licensed pharmacy.
2. Verify the compounding pharmacy: look for PCAB accreditation (or state board licensure) and ask about sterility testing, batch testing, and lot traceability.
3. Confirm the prescription and patient‑prescriber relationship meet your state’s rules (some states require an in‑person visit or specific documentation).
4. Beware of any service offering to ship injectable compounded GLP‑1s without documented medical evaluation or that bypasses state licensing — that’s unsafe and may be illegal.

Why I’m steering you away from naming “still available” compounding services

• The landscape changed quickly after the FDA letters and state actions, and a service that offered compounded GLP‑1s last month may have stopped this month. Naming a company as “still offering” could be inaccurate and unsafe.
• Compounded biologic‑like products have higher risks (potency, contamination) unless produced by a reputable, accredited compounding pharmacy under a documented medical need.

If you want, I can:

• Help you draft questions to ask a telehealth clinician or compounding pharmacy.
• Walk you through what to look for in documentation of medical necessity.
• Help you find telehealth clinics near you that prescribe FDA‑approved GLP‑1s if you tell me your state (I can’t do live web searches, but I can suggest how to search and what to verify).

Which of those would you like me to help with?